[ad_1] para el tratamiento de pacientes adultos con cáncer de pulmón de células no pequeñas (CPCNP) avanzado con una mutación BRAFV600E La aprobación europea se basa en los resultados del ensayo de fase II PHAROS, que […]
Tag: Pharmaceuticals
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
[ad_1] BEIJING and SHANGHAI and BOSTON, Aug. 30, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China rights (including mainland China, Hong Kong, […]
Ibuprofen Market to Reach $213.6 Million, Globally, by 2033 at 7.9% CAGR: Allied Market Research
[ad_1] PORTLAND, Ore., Aug. 30, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Ibuprofen Market by Type (Tablet, Capsule, Syrup, Injection, and Other), Application (Rheumatoid Arthritis and Osteoarthritis, Cancer, Pain/Fever/Dysmenorrhea, Inflammatory Diseases, Headache, and […]
Global Vaccine Adjuvants Market to Show Remarkable Growth at a CAGR of ~13% by 2030
[ad_1] The rising demand for vaccine adjuvants is mainly due to the increasing rates of infectious and cancerous diseases. Other significant factors include the heightened need for vaccines for specific illnesses, a greater emphasis on […]
Lyranda, a Breakthrough Cold Sore Treatment, is Now Available in the U.S.
[ad_1] TAMPA, Fla., Aug. 28, 2024 /PRNewswire/ — Linpharma, a global leader in high quality supplement distribution, has announced the launch of a unique and highly effective cold sore treatment, Lyranda, in the United States. […]
